1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
RNA. 2010 Feb;16(2):382-93. doi: 10.1261/rna.1955410. Epub 2010 Jan 5.
Few antivirals are effective against positive-strand RNA viruses, primarily because the high error rate during replication of these viruses leads to the rapid development of drug resistance. One of the favored current targets for the development of antiviral compounds is the active site of viral RNA-dependent RNA polymerases. However, like many subcellular processes, replication of the genomes of all positive-strand RNA viruses occurs in highly oligomeric complexes on the cytosolic surfaces of the intracellular membranes of infected host cells. In this study, catalytically inactive polymerases were shown to participate productively in functional oligomer formation and catalysis, as assayed by RNA template elongation. Direct protein transduction to introduce either active or inactive polymerases into cells infected with mutant virus confirmed the structural role for polymerase molecules during infection. Therefore, we suggest that targeting the active sites of polymerase molecules is not likely to be the best antiviral strategy, as inactivated polymerases do not inhibit replication of other viruses in the same cell and can, in fact, be useful in RNA replication complexes. On the other hand, polymerases that could not participate in functional RNA replication complexes were those that contained mutations in the amino terminus, leading to altered contacts in the folded polymerase and mutations in a known polymerase-polymerase interaction in the two-dimensional protein lattice. Thus, the functional nature of multimeric arrays of RNA-dependent RNA polymerase supplies a novel target for antiviral compounds and provides a new appreciation for enzymatic catalysis on membranous surfaces within cells.
针对正链 RNA 病毒的抗病毒药物寥寥无几,主要是因为这些病毒在复制过程中的高错误率导致了耐药性的迅速发展。目前开发抗病毒化合物的一个热门目标是病毒 RNA 依赖性 RNA 聚合酶的活性位点。然而,与许多细胞内过程一样,所有正链 RNA 病毒基因组的复制都是在感染宿主细胞的细胞内膜的细胞质表面的高度聚合复合物中进行的。在这项研究中,研究表明,无催化活性的聚合酶能够有效地参与功能性寡聚体的形成和催化,这可以通过 RNA 模板延伸来测定。直接将蛋白质转导到感染突变病毒的细胞中,以确认聚合酶分子在感染过程中的结构作用。因此,我们认为针对聚合酶分子的活性位点不太可能是最佳的抗病毒策略,因为失活的聚合酶不会抑制同一细胞中其他病毒的复制,实际上在 RNA 复制复合物中可能有用。另一方面,不能参与功能性 RNA 复制复合物的聚合酶是那些在氨基末端发生突变的聚合酶,导致折叠聚合酶中的接触改变以及二维蛋白质晶格中已知的聚合酶-聚合酶相互作用中的突变。因此,RNA 依赖性 RNA 聚合酶的多聚体阵列的功能性质为抗病毒化合物提供了一个新的靶标,并为细胞内膜上的酶催化提供了新的认识。